About Careers MedBlog Contact us

Water Pill for Alzheimer’s Treatment

by Karishma Abhishek on October 11, 2021 at 11:58 PM
Font : A-A+

Water Pill for Alzheimer’s Treatment

Water pill may be viable to test as Alzheimer's treatment as per precision medicine data dive at NIH/National Institute on Aging, published in the journal Nature Aging.

Alzheimer's disease (AD) is a neurodegenerative disease that leads to gradual memory loss and behavioral changes. It is characterized by the pathological hallmark formation of beta-amyloid plaques and the tau proteins in the brain tissues, long (almost 20 to 30 years) before the actual symptoms occur.


One of the most significant genetic risk factors for late-onset Alzheimer's is a form of the apolipoprotein E gene called APOE4.

A commonly used potent oral diuretic pill (approved by the U.S. Food and Drug Administration), - bumetanide, holds as a potential candidate for an Alzheimer's disease treatment (among 1,300 known FDA-approved drugs that was tested) especially among those who are at genetic risk.

Water Pill Treatment

The study team analyzed the effects of the drug through electronic health record data sets from more than 5 million people to two groups: adults over 65 who took bumetanide and a matching group who did not take bumetanide.

It was found that those who had the genetic risk and took bumetanide had a ~35% to 75% lower prevalence of Alzheimer's disease compared to those not taking the drug.

"We know that Alzheimer's disease will likely require specific types of treatments, perhaps multiple therapies, including some that may target an individual's unique genetic and disease characteristics — much like cancer treatments that are available today. The data in this paper make a good case to conduct a proof-of-concept trial of bumetanide in people with genetic risk," says Jean Yuan, M.D., Ph.D., Translational Bioinformatics and Drug Development program director in the NIA Division of Neuroscience.

The team had analyzed information of gene expression signatures from a database of 213 brain tissue samples and verified the same via both mouse and human cell experiments along with the human population. The study thereby advances a precision medicine approach for genetically greater risk individuals.

"Though further tests and clinical trials are needed, this research underscores the value of big data-driven tactics combined with more traditional scientific approaches to identify existing FDA-approved drugs as candidates for drug repurposing to treat Alzheimer's disease," says NIA Director Richard J. Hodes, M.D.

Source: Medindia


Recommended Reading

Latest Research News

 Experiments on Child Brain Tumour and Muscle Ageing Heading to Space
The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.
 Nearly 1 In 5 UK Adults Experience Negative Responses to Sounds
How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.
Why Are 1 in 8 Indians at Risk of Irreversible Blindness
Routine eye-checkups and mass screenings enable early diagnosis and treatment of glaucoma. Late-stage glaucoma diagnosis leads to blindness.
 Blind People Feel Their Heartbeat Better Than Those With Sight
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
New Biomarkers Help Detect Alzheimer's Disease Early
A group of scientists were awarded Ł1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Water Pill for Alzheimer’s Treatment Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests